These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10204360)

  • 1. [The effect of diltiazem on the systemic hemodynamics of patients with heart failure due to ischemic heart disease].
    Koshlia EV
    Lik Sprava; 1998 Dec; (8):97-9. PubMed ID: 10204360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem in the treatment of hypertension and ischemic heart disease.
    Barrios V
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1375-82. PubMed ID: 22059786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diltiazem ameliorates contractile dysfunction without shortening of action potential duration in ischemic heart of anesthetized dogs.
    Hamada K; Yamazaki J; Nagao T
    Jpn J Pharmacol; 2001 Jun; 86(2):251-3. PubMed ID: 11459130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythrocyte functional activity in patients with heart failure and the possible means for its correction].
    Sakharchuk II; Sisetskiĭ AP; Artiukh VP; Starodub NF
    Ter Arkh; 1992; 64(9):88-90. PubMed ID: 1481164
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
    Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
    Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina].
    Kobalava ZD; Shavarov AA; Kiyakbaev GK
    Kardiologiia; 2017 Mar; 57(3):68-74. PubMed ID: 28762939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The hemodynamic status of patients with ischemic heart disease under long-term treatment with calcium antagonists].
    Bychko MV
    Lik Sprava; 1999; (3):62-5. PubMed ID: 10474938
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical efficacy of diltiazem and the means for enhancing it in treating patients with ischemic heart disease combined with chronic bronchitis].
    Siurin AA; Ionov VA
    Kardiologiia; 1993; 33(3):20-2. PubMed ID: 8377333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of diltiazem on systemic and cerebral hemodynamics and on the blood rheological properties in patients with ischemic stroke and atherosclerotic involvement of the major cerebral arteries].
    Ishchenko MM; Hara II
    Lik Sprava; 1995; (9-12):127-31. PubMed ID: 8983753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in protective profiles of diltiazem isomers in ischemic and reperfused guinea pig hearts.
    Sato R; Sakamoto K; Yamazaki J; Nagao T
    Eur J Pharmacol; 2002 Jan; 434(3):125-31. PubMed ID: 11779575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
    Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
    Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug correction of myocardial ischemia in patients with chronic obstructive bronchitis].
    Chicherina EN; Malykh SV
    Probl Tuberk Bolezn Legk; 2003; (11):19-22. PubMed ID: 14689792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac P2X(4) receptors: targets in ischemia and heart failure?
    Yang R; Liang BT
    Circ Res; 2012 Aug; 111(4):397-401. PubMed ID: 22859669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.